DEF 14AThe Ballot
Avalo Therapeutics, Inc. files DEF 14A
Filed Apr 10, 2026 · 2mo ago · Accession 0001534120-26-000022
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Avalo Therapeutics, Inc.
- Ticker
- AVTX
- CIK
- 1534120
- Form type
- DEF 14A
- Filing date
- Apr 10, 2026
- Report date
- Apr 10, 2026
- Document
- avtx-20260408.htm
- Size
- 2.4 MB